Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (74)

Search Parameters:
Keywords = digital droplet polymerase chain reaction (ddPCR)

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 547 KiB  
Article
Analytical Validation of the Cxbladder® Triage Plus Assay for Risk Stratification of Hematuria Patients for Urothelial Carcinoma
by Justin C. Harvey, David Fletcher, Charles W. Ellen, Megan Colonval, Jody A. Hazlett, Xin Zhou and Jordan M. Newell
Diagnostics 2025, 15(14), 1739; https://doi.org/10.3390/diagnostics15141739 - 8 Jul 2025
Viewed by 388
Abstract
Background/Objectives: Cxbladder® Triage Plus is a multimodal urinary biomarker assay that combines reverse transcription-quantitative analysis of five mRNA targets and droplet-digital polymerase chain reaction (ddPCR) analysis of six DNA single-nucleotide variants (SNVs) from two genes (fibroblast growth factor receptor 3 ( [...] Read more.
Background/Objectives: Cxbladder® Triage Plus is a multimodal urinary biomarker assay that combines reverse transcription-quantitative analysis of five mRNA targets and droplet-digital polymerase chain reaction (ddPCR) analysis of six DNA single-nucleotide variants (SNVs) from two genes (fibroblast growth factor receptor 3 (FGFR3) and telomerase reverse transcriptase (TERT)) to provide risk stratification for urothelial carcinoma (UC) in patients with hematuria. This study evaluated the analytical validity of Triage Plus. Methods: The development dataset used urine samples from patients with microhematuria or gross hematuria that were previously stabilized with Cxbladder solution. Triage Plus was evaluated for predicted performance, analytical criteria (linearity, sensitivity, specificity, accuracy, and precision), extraction efficiency, and inter-laboratory reproducibility. Results: The development dataset included 987 hematuria samples. Compared with cystoscopy (standard of care), Triage Plus had a predicted sensitivity of 93.6%, specificity of 90.8%, positive predictive value (PPV) of 46.5%, negative predictive value of 99.4%, and test-negative rate of 84.1% (score threshold 0.15); the PPV increased to 74.6% for the 0.54 score threshold. For the individual FGFR3 and TERT SNVs, the limit of detection (analytical sensitivity) was a mutant-to-wild type DNA ratio of 1:440–1:1250 copies/mL. Intra- and inter-assay variance was low, while extraction efficiency was high. All other pre-specified analytical criteria (linearity, specificity, and accuracy) were met. Triage Plus showed good reproducibility (87.9% concordance between laboratories). Conclusions: Cxbladder Triage Plus accurately and reproducibly detected FGFR3 and TERT SNVs and, in combination with mRNA expression, provides a non-invasive, highly sensitive, and reproducible tool that aids in risk stratification of patients with hematuria. Full article
(This article belongs to the Special Issue Opportunities in Laboratory Medicine in the Era of Genetic Testing)
Show Figures

Figure 1

13 pages, 968 KiB  
Article
Identification of Parasitic Infections by Analyzing Honeybees, Honey, and Pollen Using Droplet Digital RT-PCR
by Luigi Jacopo D’Auria, Andrea Mancusi, Yolande Thérèse Rose Proroga, Irene Dini, Tiziana Cardellicchio, Orlandina Di Maro, Sabato De Vita, Marica Egidio, Raffaele Marrone and Giuseppe Rofrano
Microorganisms 2025, 13(7), 1487; https://doi.org/10.3390/microorganisms13071487 - 26 Jun 2025
Viewed by 379
Abstract
Toxoplasma gondii, Giardia intestinalis, and Cryptosporidium spp. are common pathogens that contaminate water and food. They can pose serious health risks, especially to vulnerable groups like immunocompromised individuals, pregnant women, young children, and aging people. An all-encompassing approach to minimizing transmission [...] Read more.
Toxoplasma gondii, Giardia intestinalis, and Cryptosporidium spp. are common pathogens that contaminate water and food. They can pose serious health risks, especially to vulnerable groups like immunocompromised individuals, pregnant women, young children, and aging people. An all-encompassing approach to minimizing transmission involves identifying effective techniques for detecting, treating, and preventing protozoan parasites. This study confirmed the effectiveness of a Droplet Digital Reverse Transcription Polymerase Chain Reaction (dd RT-PCR) method for quickly and accurately identifying Toxoplasma gondii, Giardia intestinalis, and Cryptosporidium species in honeybees, honey, and pollen by using ISO 17468 and ISO 16140 standard guidelines. The study evaluated honeybee (n = 16), honey (n = 12), and pollen (n = 8) samples collected from various apiaries in Southern Italy between June and September 2023. The results showed that honeybees, honey, and pollen can be considered bioindicators of infections by T. gondii, G. intestinalis, and Cryptosporidium spp. Furthermore, pollen, along with honey to a lesser degree, can serve as significant indicators for evaluating food safety. Therefore, it is essential to monitor their quality and purity due to environmental influences. Full article
(This article belongs to the Special Issue Advances in Genomics and Ecology of Environmental Microorganisms)
Show Figures

Figure 1

16 pages, 2795 KiB  
Article
Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with Red Beetroot Juice: Secondary Analysis of a Randomized Controlled Trial
by Emanuele Marzetti, Hélio José Coelho-Júnior, Riccardo Calvani, Giulia Girolimetti, Riccardo Di Corato, Francesca Ciciarello, Vincenzo Galluzzo, Clara Di Mario, Barbara Tolusso, Luca Santoro, Ottavia Giampaoli, Alberta Tomassini, Walter Aureli, Matteo Tosato, Francesco Landi, Cecilia Bucci, Flora Guerra and Anna Picca
Int. J. Mol. Sci. 2025, 26(3), 1224; https://doi.org/10.3390/ijms26031224 - 30 Jan 2025
Cited by 2 | Viewed by 2537
Abstract
In a recent clinical trial, beetroot juice supplementation for 14 days yielded positive effects on systemic inflammation in adults with long COVID. Here, we explored the relationship between circulating markers of mitochondrial quality and inflammation in adults with long COVID as well as [...] Read more.
In a recent clinical trial, beetroot juice supplementation for 14 days yielded positive effects on systemic inflammation in adults with long COVID. Here, we explored the relationship between circulating markers of mitochondrial quality and inflammation in adults with long COVID as well as the impact of beetroot administration on those markers. We conducted secondary analyses of a placebo-controlled randomized clinical trial testing beetroot juice supplementation as a remedy against long COVID. Analyses were conducted in 25 participants, 10 assigned to placebo (mean age: 40.2 ± 11.5 years, 60% women) and 15 allocated to beetroot juice (mean age: 38.3 ± 7.7 years, 53.3% women). Extracellular vesicles were purified from serum by ultracentrifugation and assayed for components of the electron transport chain and mitochondrial DNA (mtDNA) by Western blot and droplet digital polymerase chain reaction (ddPCR), respectively. Inflammatory markers and circulating cell-free mtDNA were quantified in serum through a multiplex immunoassay and ddPCR, respectively. Beetroot juice administration for 14 days decreased serum levels of interleukin (IL)-1β, IL-8, and tumor necrosis factor alpha, with no effects on circulating markers of mitochondrial quality control. Significant negative associations were observed between vesicular markers of mitochondrial quality control and the performance on the 6 min walk test and flow-mediated dilation irrespective of group allocation. These findings suggest that an amelioration of mitochondrial quality, possibly mediated by mitochondria-derived vesicle recycling, may be among the mechanisms supporting improvements in physical performance and endothelial function during the resolution of long COVID. Full article
(This article belongs to the Special Issue Advances in Anti-Aging Treatment Development, 2nd Edition)
Show Figures

Figure 1

45 pages, 6046 KiB  
Review
The Theoretical Basis of qPCR and ddPCR Copy Number Estimates: A Critical Review and Exposition
by James N. McNair, Daniel Frobish, Richard R. Rediske, John J. Hart, Megan N. Jamison and David C. Szlag
Water 2025, 17(3), 381; https://doi.org/10.3390/w17030381 - 30 Jan 2025
Cited by 1 | Viewed by 1597
Abstract
The polymerase chain reaction (PCR) is a molecular biology tool with diverse applications in the aquatic sciences. Classical PCR is a nonquantitative method that can be used to detect target DNA sequences that are characteristic of particular microbial taxa but cannot determine their [...] Read more.
The polymerase chain reaction (PCR) is a molecular biology tool with diverse applications in the aquatic sciences. Classical PCR is a nonquantitative method that can be used to detect target DNA sequences that are characteristic of particular microbial taxa but cannot determine their concentrations in water samples. Various quantitative forms of PCR have been developed to remove this limitation. Of these, the two that currently are used most widely are real-time quantitative PCR (qPCR) and droplet digital PCR (ddPCR). Several outlines of the mathematical and statistical basis of these methods for estimating target sequence concentrations are available in the literature, but we are aware of no thorough and rigorous derivation of the theoretical underpinnings of either. The purpose of this review is to provide such derivations, and to identify and compare the main strengths and weaknesses of the two methods. We find that both estimation methods are sound, provided careful attention is paid to specific details that differ between the two. With qPCR, it is especially important to reduce any significant PCR inhibition by sample constituents and to properly fit the standard curve to heteroskedastic calibration data. With ddPCR, it is important to ensure that the value of the mean droplet volume used in calculating concentrations is correct for the particular combination of droplet generator and master mix used. The advantages of qPCR include lower instrument and per-sample costs, a shorter turnaround time for obtaining results, a higher upper limit of quantification, and a wider dynamic range. The advantages of ddPCR include freedom from dependence on a standard curve, an inherently lower sensitivity to PCR inhibitors, a lower limit of quantification, a simpler theoretical basis, and simpler data analysis. We suggest qPCR often will be preferable in laboratory studies where investigators have significant control over the range of target sequence concentrations in samples, concentrations are sufficiently high so proper calibration does not require standards with concentrations low enough to exhibit exaggerated variability in the threshold cycle, and no significant inhibition is present, or more generally, in studies where funding levels do not permit the higher cost of instrumentation and supplies required by ddPCR or where the shorter turnaround time for qPCR is essential. If sufficient funds are available, ddPCR often will be preferable when the ability to quantify low concentrations is important, especially if inhibitors are likely to be present at concentrations that are problematic for qPCR. Full article
Show Figures

Figure 1

42 pages, 2925 KiB  
Review
Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma
by Clara Martínez-Vila, Cristina Teixido, Francisco Aya, Roberto Martín, Europa Azucena González-Navarro, Llucia Alos, Natalia Castrejon and Ana Arance
Int. J. Mol. Sci. 2025, 26(2), 861; https://doi.org/10.3390/ijms26020861 - 20 Jan 2025
Cited by 5 | Viewed by 3241
Abstract
The treatment landscape for advanced melanoma has transformed significantly with the advent of BRAF and MEK inhibitors (BRAF/MEKi) targeting BRAFV600 mutations, as well as immune checkpoint inhibitors (ICI) like anti-PD-1 monotherapy or its combinations with anti-CTLA-4 or anti-LAG-3. Despite that, many patients [...] Read more.
The treatment landscape for advanced melanoma has transformed significantly with the advent of BRAF and MEK inhibitors (BRAF/MEKi) targeting BRAFV600 mutations, as well as immune checkpoint inhibitors (ICI) like anti-PD-1 monotherapy or its combinations with anti-CTLA-4 or anti-LAG-3. Despite that, many patients still do not benefit from these treatments at all or develop resistance mechanisms. Therefore, prognostic and predictive biomarkers are needed to identify patients who should switch or escalate their treatment strategies or initiate an intensive follow-up. In melanoma, liquid biopsy has shown promising results, with a potential role in predicting relapse in resected high-risk patients or in disease monitoring during the treatment of advanced disease. Several components in peripheral blood have been analyzed, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), and circulant tumoral DNA (ctDNA), which have turned out to be particularly promising. To analyze ctDNA in blood, different techniques have proven to be useful, including digital droplet polymerase chain reaction (ddPCR) to detect specific mutations and, more recently, next-generation sequencing (NGS) techniques, which allow analyzing a broader repertoire of the mutation landscape of each patient. In this review, our goal is to update the current understanding of liquid biopsy, focusing on the use of ctDNA as a biological material in the daily clinical management of melanoma patients, in particular those with advanced disease treated with ICI. Full article
(This article belongs to the Special Issue Molecular Basis and Progress of Immunotherapy for Melanoma)
Show Figures

Figure 1

11 pages, 744 KiB  
Article
Tracking of Antibiotic Resistance Genes in Sludge from Treatment Plants for Organic Fraction of Municipal Solid Waste
by Elena Franchitti, Antonino Mafrica and Deborah Traversi
Sustainability 2024, 16(24), 10922; https://doi.org/10.3390/su162410922 - 13 Dec 2024
Viewed by 1308
Abstract
Bacteria quickly acquire the ability to survive or grow in the presence of an antibacterial agent that should be able to inhibit or kill them, leading to increased mortality caused by infective diseases. The digestate from the anaerobic digestion (AD) of the organic [...] Read more.
Bacteria quickly acquire the ability to survive or grow in the presence of an antibacterial agent that should be able to inhibit or kill them, leading to increased mortality caused by infective diseases. The digestate from the anaerobic digestion (AD) of the organic fraction of municipal solid waste (OFMSW) is spread on soil, but the knowledge on the presence and persistence of the antibiotic resistance genes (ARGs) is limited. Thus, this study aims to evaluate the presence of seven ARGs (blaTEM, blaOXA, ermB, qnrB, sulI, sulII, tetA, and tetW) in the OFMSW and their persistence after the AD, using the innovative droplet digital Polymerase Chain Reaction (ddPCR), not yet used on this matrix. A total of 31 samples were collected from the influent and effluent of the AD in two plants located in Northern Italy. ARG concentration ranged between 4 and 9 Log gene copies/kg of sludge. A limited reduction in the concentration of antibiotic resistance targets given by AD was observed in the study (<1 Log). The persistence of ARGs after mesophilic digestion of the OFMSW suggests a risk of horizontal transmission when directly spread on soil. Further evaluations are needed for safe and sustainable reuse of such sludges. Full article
Show Figures

Figure 1

15 pages, 2643 KiB  
Article
Patient-Specific Circulating Tumor DNA for Monitoring Response to Menin Inhibitor Treatment in Preclinical Models of Infant Leukemia
by Louise Doculara, Kathryn Evans, J. Justin Gooding, Narges Bayat and Richard B. Lock
Cancers 2024, 16(23), 3990; https://doi.org/10.3390/cancers16233990 - 28 Nov 2024
Viewed by 1094
Abstract
Background: In infant KMT2A (MLL1)-rearranged (MLL-r) acute lymphoblastic leukemia (ALL), early relapse and treatment response are currently monitored through invasive repeated bone marrow (BM) biopsies. Circulating tumor DNA (ctDNA) in peripheral blood (PB) provides a minimally invasive alternative, allowing for more [...] Read more.
Background: In infant KMT2A (MLL1)-rearranged (MLL-r) acute lymphoblastic leukemia (ALL), early relapse and treatment response are currently monitored through invasive repeated bone marrow (BM) biopsies. Circulating tumor DNA (ctDNA) in peripheral blood (PB) provides a minimally invasive alternative, allowing for more frequent disease monitoring. However, a poor understanding of ctDNA dynamics has hampered its clinical translation. We explored the predictive value of ctDNA for detecting minimal/measurable residual disease (MRD) and drug response in a patient-derived xenograft (PDX) model of infant MLL-r ALL. Methods: Immune-deficient mice engrafted with three MLL-r ALL PDXs were monitored for ctDNA levels before and after treatment with the menin inhibitor SNDX-50469. Results: The amount of ctDNA detected strongly correlated with leukemia burden during initial engraftment prior to drug treatment. However, following SNDX-50469 treatment, the leukemic burden assessed by either PB leukemia cells through flow cytometry or ctDNA levels through droplet digital polymerase chain reaction (ddPCR) was discrepant. This divergence could be attributed to the persistence of leukemia cells in the spleen and BM, highlighting the ability of ctDNA to reflect disease dynamics in key leukemia infiltration sites. Conclusions: Notably, ctDNA analysis proved to be a superior predictor of MRD compared to PB assessment alone, especially in instances of low disease burden. These findings highlight the potential of ctDNA as a sensitive biomarker for monitoring treatment response and detecting MRD in infant MLL-r ALL. Full article
(This article belongs to the Section Pediatric Oncology)
Show Figures

Figure 1

13 pages, 3892 KiB  
Article
Droplet Digital PCR: A New Molecular Method to Detect G1105S/V Mutations in Plasmopara viticola CesA3 Gene
by Helene Sánchez-Zelaia, Irene Maja Nanni, Ivano Oggiano, Mónica Hernández, Ana María Díez-Navajas and Marina Collina
Biology 2024, 13(11), 919; https://doi.org/10.3390/biology13110919 - 13 Nov 2024
Cited by 1 | Viewed by 1143
Abstract
Plasmopara viticola is the causal agent of Grapevine Downy Mildew (GDM), which is a devastating disease of grapevines in humid temperate regions. The most employed method for protecting grapevines against GDM is the application of chemical fungicides. In Spain, Carboxylic Acid Amides (CAAs) [...] Read more.
Plasmopara viticola is the causal agent of Grapevine Downy Mildew (GDM), which is a devastating disease of grapevines in humid temperate regions. The most employed method for protecting grapevines against GDM is the application of chemical fungicides. In Spain, Carboxylic Acid Amides (CAAs) are a fungicide group currently utilized in GDM control. In P. viticola, resistance to CAAs is conferred by G1105S and G1105V mutations in the CesA3 gene. Droplet digital polymerase chain reaction (ddPCR) is an innovative technique that combines PCR and droplet microfluidics to disperse the sample into thousands of water-in-oil droplets in which an amplification reaction is individually performed. In this study, we set up a ddPCR protocol to quantify S1105 and V1105 mutations conferring resistance to CAAs in P. viticola. The optimal PCR conditions were established, and the sensitivity and precision of the protocol were assessed. Four P. viticola populations coming from commercial vineyards in northern Spain were analyzed, and different allele frequencies were found in the analyzed samples corresponding to the different fungicide management strategies, ranging from 7.72% to 100%. Knowing the level of mutated alleles allows for designing resistance management strategies suited for each location. This suggests that similar ddPCR assays could be developed for studying mutations implicated in fungicide resistance in other fungicide groups and plant pathogens. Full article
Show Figures

Figure 1

16 pages, 795 KiB  
Review
Detecting Dirofilaria immitis: Current Practices and Novel Diagnostic Methods
by Damian Pietrzak, Julia Weronika Łuczak and Marcin Wiśniewski
Pathogens 2024, 13(11), 950; https://doi.org/10.3390/pathogens13110950 - 31 Oct 2024
Cited by 1 | Viewed by 2916
Abstract
The nematode Dirofilaria immitis is responsible for a vector-borne disease affecting canines and humans worldwide, known as cardiopulmonary dirofilariasis. An accurate and early diagnosis is of the utmost importance for effective disease management. While traditional microscopy-based methods remain invaluable, they have inherent limitations. [...] Read more.
The nematode Dirofilaria immitis is responsible for a vector-borne disease affecting canines and humans worldwide, known as cardiopulmonary dirofilariasis. An accurate and early diagnosis is of the utmost importance for effective disease management. While traditional microscopy-based methods remain invaluable, they have inherent limitations. Serological tests, in particular ELISA and immunochromatographic tests, are employed due to their capacity to detect D. immitis antigens, offering ease of use and diagnostic accuracy. The advent of molecular methods has the potential to enhance routine diagnostic approaches, with polymerase chain reaction (PCR) and real-time PCR (qPCR) becoming the most prevalent techniques. Despite not yet being integrated into routine diagnostics, which are predominantly based on the Knott’s test and serological methods, these techniques offer significant benefits in the context of scientific research. This article proceeds to examine the potential of advanced techniques, such as high-resolution melting qPCR (HRM-qPCR), loop-mediated isothermal amplification (LAMP), droplet digital PCR (ddPCR), and microRNA (miRNA) detection, which are capable of enhanced sensitivity and early detection. The following work provides an in-depth analysis of the various diagnostic methods, emphasising the necessity of the continuous improvement and adaptation of these tools to effectively combat D. immitis. The findings underscore the importance of integrating these advanced methods into routine practice to improve detection rates and outcomes for infected animals. Full article
(This article belongs to the Special Issue Research on the Epidemiology and Transmission of Filarial Diseases)
Show Figures

Figure 1

27 pages, 2386 KiB  
Review
Detection Methods for Pine Wilt Disease: A Comprehensive Review
by Sana Tahir, Syed Shaheer Hassan, Lu Yang, Miaomiao Ma and Chenghao Li
Plants 2024, 13(20), 2876; https://doi.org/10.3390/plants13202876 - 14 Oct 2024
Cited by 11 | Viewed by 3483
Abstract
Pine wilt disease (PWD), caused by the nematode Bursaphelenchus xylophilus, is a highly destructive forest disease that necessitates rapid and precise identification for effective management and control. This study evaluates various detection methods for PWD, including morphological diagnosis, molecular techniques, and remote [...] Read more.
Pine wilt disease (PWD), caused by the nematode Bursaphelenchus xylophilus, is a highly destructive forest disease that necessitates rapid and precise identification for effective management and control. This study evaluates various detection methods for PWD, including morphological diagnosis, molecular techniques, and remote sensing. While traditional methods are economical, they are limited by their inability to detect subtle or early changes and require considerable time and expertise. To overcome these challenges, this study emphasizes advanced molecular approaches such as real-time polymerase chain reaction (RT-PCR), droplet digital PCR (ddPCR), and loop-mediated isothermal amplification (LAMP) coupled with CRISPR/Cas12a, which offer fast and accurate pathogen detection. Additionally, DNA barcoding and microarrays facilitate species identification, and proteomics can provide insights into infection-specific protein signatures. The study also highlights remote sensing technologies, including satellite imagery and unmanned aerial vehicle (UAV)-based hyperspectral analysis, for their capability to monitor PWD by detecting asymptomatic diseases through changes in the spectral signatures of trees. Future research should focus on combining traditional and innovative techniques, refining visual inspection processes, developing rapid and portable diagnostic tools for field application, and exploring the potential of volatile organic compound analysis and machine learning algorithms for early disease detection. Integrating diverse methods and adopting innovative technologies are crucial to effectively control this lethal forest disease. Full article
(This article belongs to the Special Issue Biotechnology and Genetic Engineering in Forest Trees)
Show Figures

Figure 1

11 pages, 2337 KiB  
Article
Integration of Whole-Genome Sequencing with ddPCR Kit for Detection of Omicron Subvariants in Wastewater in the Upper Peninsula of Michigan
by Michelle M. Jarvie, Thu N. T. Nguyen, Benjamin Southwell and Derek Wright
Appl. Microbiol. 2024, 4(4), 1453-1463; https://doi.org/10.3390/applmicrobiol4040100 - 13 Oct 2024
Viewed by 1264
Abstract
This study explores the integration of genome sequencing and digital droplet polymerase chain reaction (ddPCR)-based methods for tracking the diversity of COVID-19 variants in wastewater. The research focuses on monitoring various Omicron subvariants during a period of significant viral evolution. Genome sequencing, particularly [...] Read more.
This study explores the integration of genome sequencing and digital droplet polymerase chain reaction (ddPCR)-based methods for tracking the diversity of COVID-19 variants in wastewater. The research focuses on monitoring various Omicron subvariants during a period of significant viral evolution. Genome sequencing, particularly using Oxford Nanopore Technology (ONT), provides a detailed view of emerging variants, surpassing the limitations of PCR-based detection kits that rely on known sequences. Of the 43 samples analyzed, 39.5% showed matching results between the GT Molecular ddPCR kits and sequencing, though only 4% were exact matches. Some mismatches occurred due to newer subvariants like XBB and BQ.1, which the ddPCR kits could not detect. This emphasized the limitations of ddPCR kits, which rely on known variant sequences, while sequencing provides real-time data on emerging variants, offering a more comprehensive view of circulating strains. This study highlights the effectiveness of combining these methodologies to enhance early detection and inform public health strategies, especially in regions with limited clinical sequencing capabilities. Full article
Show Figures

Figure 1

7 pages, 430 KiB  
Brief Report
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR
by Filippo Russo, Speranza Esposito, Lorella Tripodi, Savio Domenico Pandolfo, Achille Aveta, Felice Amato, Carmela Nardelli, Ciro Imbimbo, Lucio Pastore and Giuseppe Castaldo
Microorganisms 2024, 12(10), 2049; https://doi.org/10.3390/microorganisms12102049 - 10 Oct 2024
Cited by 7 | Viewed by 1361
Abstract
To date, the increased awareness of the impact of microbes on human health has promoted scientific interest in microbiome studies for diagnostic and therapeutic purposes, revealing correlations between specific taxa and cancer. In particular, numerous species of Porphyromonas have been associated with several [...] Read more.
To date, the increased awareness of the impact of microbes on human health has promoted scientific interest in microbiome studies for diagnostic and therapeutic purposes, revealing correlations between specific taxa and cancer. In particular, numerous species of Porphyromonas have been associated with several types of tumors. Previously, we studied the urobiome using Next-Generation Sequencing (NGS), and found an increase in Porphyromonas somerae in first morning urine of subjects affected by bladder cancer (BCa). Here, we aimed to confirm the presence of P. somerae in BCa patients by using droplet digital Polymerase Chain Reaction (ddPCR), testing a cohort of 102 male subjects over 50 years. Our findings showed a significant increase in P. somerae in the urine of the BCa group within both ddPCR and NGS, and a correlation between the two methods was observed at a statistical level. Moreover, P. somerae’s identification with ddPCR confirmed a significant association between this bacterium and the presence of BCa, highlighting its potential role as a biomarker. This allows us to propose the ddPCR as a suitable method for first-stage BCa screening and follow-up. Full article
(This article belongs to the Special Issue Microbiome and Genitourinary Diseases)
Show Figures

Figure 1

18 pages, 1394 KiB  
Review
Detection of the BRAFV600E Mutation in Circulating Free Nucleic Acids as a Biomarker of Thyroid Cancer: A Review
by Emilia Niedziela, Łukasz Niedziela, Aldona Kowalska and Artur Kowalik
J. Clin. Med. 2024, 13(18), 5396; https://doi.org/10.3390/jcm13185396 - 12 Sep 2024
Cited by 1 | Viewed by 1990
Abstract
Background: Liquid biopsy is a method that could potentially improve the management of thyroid cancer (TC) by enabling the detection of circulating tumor DNA and RNA (ctDNA, ctRNA). The BRAFV600E mutation appears to be the most representative example of a biomarker [...] Read more.
Background: Liquid biopsy is a method that could potentially improve the management of thyroid cancer (TC) by enabling the detection of circulating tumor DNA and RNA (ctDNA, ctRNA). The BRAFV600E mutation appears to be the most representative example of a biomarker in liquid biopsy, as it is the most specific mutation for TC and a target for molecular therapeutics. The aim of this review is to summarize the available data on the detection of the BRAFV600E mutation in liquid biopsy in patients with TC. Methods: A comprehensive analysis of the available literature on the detection of the BRAFV600E mutation in liquid biopsy in TC was performed. Thirty-three papers meeting the inclusion criteria were selected after full-text evaluation. Results: Eleven papers discussed correlations between BRAF mutation and clinicopathological characteristics. Nine studies tested the utility of BRAFV600E detection in the assessment of residual or recurrent disease. Seven studies investigated BRAF-mutated circulating tumor nucleic acids (ctNA) as a marker of response to targeted therapy. In seven studies the method did not detect the BRAFV600E mutation. Conclusions: This review shows the potential of BRAFV600E-mutated ctNA detection in monitoring disease progression, particularly in advanced TC. The diagnostic value of BRAFV600E-mutated ctNA detection appears to be limited to advanced TC. The choice of the molecular method (quantitative PCR [qPCR], droplet digital polymerase chain reaction [ddPCR], and next-generation sequencing [NGS]) should be made based on the turnaround time, sensitivity of the test, and the clinical indications. Despite the promising outcomes of some studies, there is a need to verify these results on larger cohorts and to unify the molecular methods. Full article
(This article belongs to the Special Issue Endocrine Malignancies: Current Surgical Therapeutic Approaches)
Show Figures

Figure 1

22 pages, 4650 KiB  
Article
The Impact of Liquid Biopsy in Advanced Ovarian Cancer Care
by Antoni Llueca, Sarai Canete-Mota, Anna Jaureguí, Manuela Barneo, Maria Victoria Ibañez, Alexander Neef, Enrique Ochoa, Sarai Tomas-Perez, Josep Mari-Alexandre, Juan Gilabert-Estelles, Anna Serra, Maria Teresa Climent, Carla Bellido, Nuria Ruiz, Blanca Segarra-Vidal and Maria Llueca
Diagnostics 2024, 14(17), 1868; https://doi.org/10.3390/diagnostics14171868 - 26 Aug 2024
Cited by 2 | Viewed by 2039
Abstract
Introduction: Ovarian cancer is the third most common gynaecological cancer and has a very high mortality rate. The cornerstone of treatment is complete debulking surgery plus chemotherapy. Even with treatment, 80% of patients have a recurrence. Circulating tumour DNA (ctDNA) has been shown [...] Read more.
Introduction: Ovarian cancer is the third most common gynaecological cancer and has a very high mortality rate. The cornerstone of treatment is complete debulking surgery plus chemotherapy. Even with treatment, 80% of patients have a recurrence. Circulating tumour DNA (ctDNA) has been shown to be useful in the control and follow-up of some tumours. It could be an option to define complete cytoreduction and for the early diagnosis of recurrence. Objective: We aimed to demonstrate the usefulness of ctDNA and cell-free DNA (cfDNA) as a marker of complete cytoreduction and during follow-up in patients with advanced ovarian cancer. Material and Methods: We selected 22 women diagnosed with advanced high-grade serous ovarian cancer, of which only 4 had complete records. We detected cfDNA by polymerase chain reaction (PCR), presented as ng/mL, and detected ctDNA with droplet digital PCR (ddPCR). We calculated Pearson correlation coefficients to evaluate correlations among cfDNA, ctDNA, and cancer antigen 125 (CA125), a biomarker. Results: The results obtained in the evaluation of cfDNA and ctDNA and their correlation with tumour markers and the radiology of patients with complete follow-up show disease progression during the disease, stable disease, or signs of recurrence. cfDNA and ctDNA correlated significantly with CA125. Following cfDNA and ctDNA over time indicated a recurrence several months earlier than computed tomography and CA125 changes. Conclusion: An analysis of cfDNA and ctDNA offers a non-invasive clinical tool for monitoring the primary tumour to establish a complete cytoreduction and to diagnose recurrence early. Full article
(This article belongs to the Special Issue Pathology and Diagnosis of Ovarian Cancer)
Show Figures

Figure 1

15 pages, 4033 KiB  
Article
Vertical Intrauterine Bovine and Ovine Papillomavirus Coinfection in Pregnant Cows
by Francesca De Falco, Anna Cutarelli, Leonardo Leonardi, Ioan Marcus and Sante Roperto
Pathogens 2024, 13(6), 453; https://doi.org/10.3390/pathogens13060453 - 26 May 2024
Cited by 3 | Viewed by 1476
Abstract
There is very little information available about transplacental infections by the papillomavirus in ruminants. However, recent evidence has emerged of the first report of vertical infections of bovine papillomavirus (BPV) in fetuses from naturally infected, pregnant cows. This study reports the coinfection of [...] Read more.
There is very little information available about transplacental infections by the papillomavirus in ruminants. However, recent evidence has emerged of the first report of vertical infections of bovine papillomavirus (BPV) in fetuses from naturally infected, pregnant cows. This study reports the coinfection of BPV and ovine papillomavirus (OaPV) in bovine fetuses from infected pregnant cows suffering from bladder tumors caused by simultaneous, persistent viral infections. Some molecular mechanisms involving the binary complex composed of Eras and platelet-derived growth factor β receptor (PDGFβR), by which BPVs and OaPVs contribute to reproductive disorders, have been investigated. A droplet digital polymerase chain reaction (ddPCR) was used to detect and quantify the nucleic acids of the BPVs of the Deltapapillomavirus genus (BPV1, BPV2, BPV13, and BPV14) and OaPVs belonging to the Deltapapillomavirus (OaPV1, OaPV2, and OaPV4) and Dyokappapapillomavirus (OaPV3) genera in the placenta and fetal organs (heart, lung, liver, and kidneys) of four bovine fetuses from four pregnant cows with neoplasia of the urinary bladder. A papillomaviral evaluation was also performed on the bladder tumors and peripheral blood of these pregnant cows. In all fetal and maternal samples, the genotype distribution of BPVs and OaPVs were evaluated using both their DNA and RNA. A BPV and OaPV coinfection was seen in bladder tumors, whereas only BPV infection was found in peripheral blood. The genotype distribution of both the BPVs and OaPVs detected in placentas and fetal organs indicated a stronger concordance with the viral genotypes detected in bladder tumors rather than in peripheral blood. This suggests that the viruses found in placentas and fetuses may have originated from infected bladders. Our study highlights the likelihood of vertical infections with BPVs and OaPVs and emphasizes the importance of gaining further insights into the mechanisms and consequences of this exposure. This study warrants further research as adverse pregnancy outcomes are a major source of economic losses in cattle breeding. Full article
(This article belongs to the Special Issue Updates on Animal Papillomaviruses)
Show Figures

Figure 1

Back to TopTop